Huifang Zong

Title: Huifang Zong: Innovator in Tumor Immunotherapy

Introduction

Huifang Zong is a notable inventor based in Shanghai, China. He has made significant contributions to the field of tumor immunotherapy through his innovative research and development.

Latest Patents

Huifang Zong holds a patent for a polypeptide combination used for tumor immunotherapy, along with its preparation method. This invention includes a targeting component that comprises a shielding peptide, a cleavable part, an antigen-binding part, and a first intein fragment. The shielding peptide and the antigen-binding part are connected via the cleavable part, while the antigen-binding part is linked to the first intein fragment. Additionally, the toxin component consists of a second intein fragment and a toxin, which are also interconnected. This immunoconjugate is designed to enhance the efficacy of tumor treatment.

Career Highlights

Throughout his career, Huifang Zong has worked with reputable organizations, including Jecho Institute, Co., Ltd. and Jecho Laboratories Inc. His work has focused on advancing therapeutic methods in the medical field, particularly in immunotherapy.

Collaborations

Huifang Zong has collaborated with notable colleagues, including Jianwei Zhu and Jing Wang, who have contributed to his research endeavors.

Conclusion

Huifang Zong's innovative work in tumor immunotherapy exemplifies the impact of scientific research on medical advancements. His contributions continue to pave the way for future developments in the field.